- Home
- OSTX vs SRZN Comparison
OSTX vs SRZN Comparison
Compare OSTX & SRZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OSTX
- SRZN
- Stock Information
- Founded
- OSTX 2018
- SRZN 2015
- Country
- OSTX United States
- SRZN United States
- Employees
- OSTX N/A
- SRZN N/A
- Industry
- OSTX
- SRZN Medicinal Chemicals and Botanical Products
- Sector
- OSTX
- SRZN Health Care
- Exchange
- OSTX NYSE
- SRZN Nasdaq
- Market Cap
- OSTX 39.1M
- SRZN 33.0M
- IPO Year
- OSTX 2024
- SRZN N/A
- Fundamental
- Price
- OSTX $1.70
- SRZN $11.20
- Analyst Decision
- OSTX Strong Buy
- SRZN Strong Buy
- Analyst Count
- OSTX 2
- SRZN 2
- Target Price
- OSTX $17.50
- SRZN $38.50
- AVG Volume (30 Days)
- OSTX 2.3M
- SRZN 28.0K
- Earning Date
- OSTX 03-04-2025
- SRZN 04-09-2025
- Dividend Yield
- OSTX N/A
- SRZN N/A
- EPS Growth
- OSTX N/A
- SRZN N/A
- EPS
- OSTX N/A
- SRZN N/A
- Revenue
- OSTX N/A
- SRZN $10,000,000.00
- Revenue This Year
- OSTX N/A
- SRZN N/A
- Revenue Next Year
- OSTX $26,663.99
- SRZN N/A
- P/E Ratio
- OSTX N/A
- SRZN N/A
- Revenue Growth
- OSTX N/A
- SRZN N/A
- 52 Week Low
- OSTX $1.58
- SRZN $6.00
- 52 Week High
- OSTX $7.00
- SRZN $18.17
- Technical
- Relative Strength Index (RSI)
- OSTX N/A
- SRZN 49.20
- Support Level
- OSTX N/A
- SRZN $11.25
- Resistance Level
- OSTX N/A
- SRZN $12.55
- Average True Range (ATR)
- OSTX 0.00
- SRZN 0.97
- MACD
- OSTX 0.00
- SRZN 0.11
- Stochastic Oscillator
- OSTX 0.00
- SRZN 55.74
About OSTX OS THERAPIES INCORPORATED
OS Therapies Inc is a clinical stage biopharmaceutical company focused on the identification, development and commercialization of treatments for Osteosarcoma (OS) and other solid tumors. The companys mission is to address the significant need for new treatments in cancers of the bone in children and young adults.
About SRZN Surrozen Inc.
Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-1326 (Fzd5/Lrp6, SWAP), SZN-413 and SZN-043 (E3/ASGR1, SWEETS).